XML 55 R43.htm IDEA: XBRL DOCUMENT v3.20.2

Long-Term Investments (Details 1)	9 Months Ended
	Sep. 30, 2020
BioFirst Corporation [Member]
Relationship with the Company and its subsidiaries, description	Entity controlled by controlling beneficiary shareholder of Yuangene
Braingenesis Biotechnology Co., Ltd. [Member]
Relationship with the Company and its subsidiaries, description	No specific business relationship
Genepharm Biotech Corporation [Member]
Relationship with the Company and its subsidiaries, description	No specific business relationship
BioHopeKing Corporation [Member]
Relationship with the Company and its subsidiaries, description	Collaborating with the Company to develop and commercialize drugs
Rgene Corporation [Member]
Relationship with the Company and its subsidiaries, description	Collaborating with the Company to develop and commercialize drugs

X

- Definition

It represents related party descriptions.

+ References

No definition available.

+ Details

Name:	abvcd_RelatedPartyTransactionDescriptionOfTransactions
Namespace Prefix:	abvcd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=abvcd_BioFirstCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_GenepharmBiotechCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_BioHopeKingCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_RgeneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: